Compare Neurocrine Biosciences Inc (NBIX) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Uranium Energy Corp — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Uranium Energy Corp trades at $9.6 (market cap $4.65B). The key difference: Neurocrine Biosciences Inc is far larger — about 3.7× Uranium Energy Corp's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.
| NBIX | UEC | |
|---|---|---|
Market Cap | $17.40B | $4.65B |
Sector | Health | Energy |
52-Week High | $180.55 | $20.14 |
52-Week Low | $123.10 | $8.00 |
Enterprise Value | $16.49B | $4.16B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
